Titre : Hémiplégie

Hémiplégie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Clinical Coding
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémiplégie : Questions médicales les plus fréquentes", "headline": "Hémiplégie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémiplégie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémiplégie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Paralysie", "url": "https://questionsmedicales.fr/mesh/D010243", "about": { "@type": "MedicalCondition", "name": "Paralysie", "code": { "@type": "MedicalCode", "code": "D010243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636" } } }, "about": { "@type": "MedicalCondition", "name": "Hémiplégie", "alternateName": "Hemiplegia", "code": { "@type": "MedicalCode", "code": "D006429", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohamad A Mikati", "url": "https://questionsmedicales.fr/author/Mohamad%20A%20Mikati", "affiliation": { "@type": "Organization", "name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC. mohamad.mikati@dm.duke.edu." } }, { "@type": "Person", "name": "Lyndsey Prange", "url": "https://questionsmedicales.fr/author/Lyndsey%20Prange", "affiliation": { "@type": "Organization", "name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC." } }, { "@type": "Person", "name": "Julie Uchitel", "url": "https://questionsmedicales.fr/author/Julie%20Uchitel", "affiliation": { "@type": "Organization", "name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC." } }, { "@type": "Person", "name": "April Boggs", "url": "https://questionsmedicales.fr/author/April%20Boggs", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA." } }, { "@type": "Person", "name": "Milton Pratt", "url": "https://questionsmedicales.fr/author/Milton%20Pratt", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Paraneoplastic encephalitis: clinically based approach on diagnosis and management.", "datePublished": "2023-04-10", "url": "https://questionsmedicales.fr/article/37036000", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/postmj/postgradmedj-2022-141766" } }, { "@type": "ScholarlyArticle", "name": "Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management.", "datePublished": "2023-04-10", "url": "https://questionsmedicales.fr/article/37036624", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11912-023-01416-2" } }, { "@type": "ScholarlyArticle", "name": "Radiation-induced bystander effect and its clinical implications.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37091174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2023.1124412" } }, { "@type": "ScholarlyArticle", "name": "A clinical perspective of chitosan nanoparticles for infectious disease management.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37362954", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00289-023-04755-z" } }, { "@type": "ScholarlyArticle", "name": "Current clinical understanding and effectiveness of portopulmonary hypertension treatment.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37081835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmed.2023.1142836" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Paralysie", "item": "https://questionsmedicales.fr/mesh/D010243" }, { "@type": "ListItem", "position": 6, "name": "Hémiplégie", "item": "https://questionsmedicales.fr/mesh/D006429" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémiplégie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémiplégie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémiplégie", "description": "Comment diagnostique-t-on l'hémiplégie ?\nQuels tests sont utilisés pour évaluer l'hémiplégie ?\nL'électromyographie est-elle utile ?\nQuels signes cliniques indiquent l'hémiplégie ?\nL'hémiplégie peut-elle être confondue avec d'autres conditions ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Clinical+Coding&page=999#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémiplégie", "description": "Quels sont les symptômes de l'hémiplégie ?\nL'hémiplégie affecte-t-elle la sensibilité ?\nPeut-on avoir des douleurs avec l'hémiplégie ?\nY a-t-il des troubles cognitifs associés ?\nL'hémiplégie peut-elle causer des problèmes émotionnels ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Clinical+Coding&page=999#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémiplégie", "description": "Comment prévenir l'hémiplégie ?\nL'exercice régulier aide-t-il ?\nUne alimentation saine est-elle importante ?\nFaut-il éviter le tabac ?\nLe stress peut-il influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Clinical+Coding&page=999#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémiplégie", "description": "Quels traitements sont disponibles pour l'hémiplégie ?\nLa physiothérapie est-elle efficace ?\nDes médicaments sont-ils prescrits ?\nLa chirurgie est-elle une option ?\nQuelles sont les approches complémentaires ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Clinical+Coding&page=999#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémiplégie", "description": "Quelles complications peuvent survenir ?\nL'hémiplégie peut-elle entraîner des problèmes respiratoires ?\nY a-t-il un risque de thrombose ?\nDes troubles de la peau peuvent-ils se développer ?\nL'hémiplégie peut-elle affecter la santé mentale ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Clinical+Coding&page=999#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémiplégie", "description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe mode de vie influence-t-il le risque ?\nLe stress est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Clinical+Coding&page=999#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on l'hémiplégie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des imageries cérébrales comme l'IRM." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'hémiplégie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests neurologiques et des évaluations fonctionnelles sont utilisés pour mesurer la gravité." } }, { "@type": "Question", "name": "L'électromyographie est-elle utile ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à évaluer la fonction musculaire et la conduction nerveuse." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent l'hémiplégie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent une faiblesse unilatérale, des réflexes anormaux et des troubles de la coordination." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle être confondue avec d'autres conditions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres troubles neurologiques comme l'hémiparésie." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hémiplégie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une paralysie d'un côté, des troubles de la parole et des difficultés motrices." } }, { "@type": "Question", "name": "L'hémiplégie affecte-t-elle la sensibilité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des pertes de sensation ou des sensations anormales du côté affecté." } }, { "@type": "Question", "name": "Peut-on avoir des douleurs avec l'hémiplégie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs neuropathiques ou musculo-squelettiques peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des troubles cognitifs associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle causer des problèmes émotionnels ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes comme la dépression et l'anxiété sont fréquents après un AVC." } }, { "@type": "Question", "name": "Comment prévenir l'hémiplégie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le contrôle des facteurs de risque comme l'hypertension et le diabète." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut réduire le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Une alimentation saine est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée aide à maintenir une bonne santé cardiovasculaire." } }, { "@type": "Question", "name": "Faut-il éviter le tabac ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque d'AVC et d'hémiplégie." } }, { "@type": "Question", "name": "Le stress peut-il influencer le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à des problèmes de santé augmentant le risque d'AVC." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'hémiplégie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la rééducation physique, l'ergothérapie et des médicaments." } }, { "@type": "Question", "name": "La physiothérapie est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie aide à améliorer la mobilité et la force musculaire." } }, { "@type": "Question", "name": "Des médicaments sont-ils prescrits ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les anticoagulants ou les anti-inflammatoires peuvent être prescrits." } }, { "@type": "Question", "name": "La chirurgie est-elle une option ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour traiter des complications." } }, { "@type": "Question", "name": "Quelles sont les approches complémentaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme l'acupuncture ou la thérapie par le mouvement peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des problèmes de déglutition et des contractures." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle entraîner des problèmes respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes respiratoires peuvent survenir en raison de la faiblesse musculaire." } }, { "@type": "Question", "name": "Y a-t-il un risque de thrombose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de thrombose veineuse profonde est accru chez les patients hémiplégiques." } }, { "@type": "Question", "name": "Des troubles de la peau peuvent-ils se développer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des escarres peuvent se former en raison d'une immobilité prolongée." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle affecter la santé mentale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles mentaux comme la dépression sont fréquents après un AVC." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'hémiplégie augmente avec l'âge, surtout après 55 ans." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'AVC augmentent le risque d'hémiplégie." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à des problèmes cardiovasculaires et d'AVC." } } ] } ] }

Sources (10000 au total)

Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management.

Intracranial germinomas constitute a rare brain tumor entity of unknown etiology, characterized by unique histopathology and molecular biology. In this manuscript, we review the literature focusing on... Although the optimal treatment strategy remains a matter of debate, intracranial germinomas respond well to radiotherapy, chemotherapy, or a combination of both and are characterized by very high cure...

Clinical features and "early" corticosteroid treatment outcome of pediatric

Many children with... Patients who had pulmonary infiltrations on chest imaging within 5 days of the disease course and were suspected of having MP infection on admission were enrolled. Among them, patients whose disease c... A total of 210 patients with confirmed MPP were ultimately enrolled. There were 59 patients in Group A and 151 patients in Group B. Patients in Group A were more prone to have allergy histories, hypox... In hospitalized patients with MPP, particularly severe MPP, the ideal starting time of corticosteroid treatment might be 5-10 days, preferably 6-7 days, after disease onset. The initial dosage of cort...

Glaucoma triage system: results of implementing a virtual clinic.

This study describes the virtual clinic triage system implementation process at Hospital Santa Maria-Centro Hospitalar Universitário Lisboa Norte (HSM-CHULN) and analyzes its results regarding healthc... A retrospective analysis was performed, comparing two cohorts (pre-virtual cohort; virtual triage cohort). Outcomes related to waiting time, number of hospital visits, decisions at first contact, and ... Two hundred and ninety-two charts were reviewed (pre-virtual cohort: 132; virtual cohort: 160). Mean waiting time between referral and the first medical contact with the glaucoma department decreased ... Our virtual screening strategy significantly decreased waiting time, number of hospital visits, and increased chances of data-assisted clinical decision. While results can be further improved, this sy...

Evaluation of clinical characteristics and risk factors of strabismus cases.

Strabismus, defined as the misalignment of the eyes, is a common disorder that is usually diagnosed in childhood. Strabismus is an important health problem with both functional and psychosocial effect... The data of pediatric patients who were followed up in our strabismus clinic between February 2016 and September 2022 were retrospectively reviewed. The patients' detailed ophthalmological and strabis... A total of 391 patients were enrolled in the study. The mean age of the patients was 8.66±4.7 years. Of the patients, 207 (52.9%) had esotropia, 172 (43.99%) had exotropia, and 12 (3.07%) had vertical... Detection of risk factors such as family history, preterm birth, length of stay in the neonatal care unit and epilepsy that may be associated with strabismus can help identify high-risk children for e...